INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

More about accessibility

Trouble using our website?
Contact us

Text logo ERN-EYE Tools
CPMS REDgistry Elearning Members area
Accessibility

A Post-Authorization, Multicenter, Multinational, Longitudinal, Observational Safety Registry Study for Patients Treated with Voretigene Neparvovec

In this page

Clinical Trial

CLTW888A12401 Recruiting, Active
A Post-Authorization, Multicenter, Multinational, Longitudinal, Observational Safety Registry Study for Patients Treated with Voretigene Neparvovec
Observational

Disease

Disease type

Retinitis Pigmentosa

Inclusion / Exclusion

Opening date

18/12/2019

Closing date

01/11/2029

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Industry

ERN EYE member investigating site

HCP : Principal investigators

More